Amdocs Ltd

Company Profile

Amdocs Ltd had its IPO on 1998-06-19 under the ticker symbol DOX.

The company operates in the Technology sector and Software-Infrastructure industry. Amdocs Ltd has a staff strength of 31,000 employees.

Stock update

Shares of Amdocs Ltd opened at $93.62 at the start of the last trading session i.e. 2023-03-24.

The stocks traded within a range of $92.67 - $94.1, and closed at $94.

This is a +0.99% increase from the previous day's closing price.

A total volume of 655,236 shares were traded at the close of the day’s session.

In the last one week, shares of Amdocs Ltd have increased by +2.9%.

Amdocs Ltd's Key Ratios

Amdocs Ltd has a market cap of $11.19 billion, indicating a price to book ratio of 3.0586 and a price to sales ratio of 2.3432.

In the last 12-months Amdocs Ltd’s revenue was $4.66 billion with a gross profit of $1.62 billion and an EBITDA of $913.99 million. The EBITDA ratio measures Amdocs Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Amdocs Ltd’s operating margin was 14.58% while its return on assets stood at 6.52% with a return of equity of 15.23%.

In Q4, Amdocs Ltd’s quarterly earnings growth was a positive 0.1% while revenue growth was a positive 7.3%.

Amdocs Ltd’s PE and PEG Ratio

Forward PE

15.0376

Trailing PE

20.8027

PEG

1.1561

Its diluted EPS in the last 12-months stands at $4.46 per share while it has a forward price to earnings multiple of 15.0376 and a PEG multiple of 1.1561. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amdocs Ltd’s profitability.

Amdocs Ltd stock is trading at a EV to sales ratio of 2.3528 and a EV to EBITDA ratio of 11.9736. Its price to sales ratio in the trailing 12-months stood at 2.3432.

Amdocs Ltd stock pays annual dividends of $1.58 per share, indicating a yield of 1.87% and a payout ratio of 29.19%.

Balance sheet and cash flow metrics

Total Assets

$6.46 billion

Total Liabilities

$1.33 billion

Operating Cash Flow

$0

Capital Expenditure

$33.70 million

Dividend Payout Ratio

29.19%

Amdocs Ltd ended 2023 with $6.46 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $6.46 billion while shareholder equity stood at $3.55 billion.

Amdocs Ltd ended 2023 with $0 in deferred long-term liabilities, $1.33 billion in other current liabilities, in common stock, $6.29 billion in retained earnings and $2.66 billion in goodwill. Its cash balance stood at $492.18 million and cash and short-term investments were $734.56 million. The company’s total short-term debt was $39,724,000 while long-term debt stood at $645.26 million.

Amdocs Ltd’s total current assets stands at $2.08 billion while long-term investments were $0 and short-term investments were $242.38 million. Its net receivables were $1.14 billion compared to accounts payable of $228.52 million and inventory worth $0.

In 2023, Amdocs Ltd's operating cash flow was $0 while its capital expenditure stood at $33.70 million.

Comparatively, Amdocs Ltd paid $0.29 in dividends in 2023.

Other key metrics

Current Trading Price

$94

52-Week High

$97.08

52-Week Low

$75.3662

Analyst Target Price

$92.83

Amdocs Ltd stock is currently trading at $94 per share. It touched a 52-week high of $97.08 and a 52-week low of $97.08. Analysts tracking the stock have a 12-month average target price of $92.83.

Its 50-day moving average was $92.51 and 200-day moving average was $86.05 The short ratio stood at 1.45 indicating a short percent outstanding of 0%.

Around 1.3% of the company’s stock are held by insiders while 9870.4% are held by institutions.